|
PAIP2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.24289508976972E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.43520001122988E-09 |
| Normal-vs-Stage2 |
5.713800E-01 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62747593179802E-12 |
| Stage1-vs-Stage2 |
7.440000E-02 |
| Stage1-vs-Stage3 |
7.036100E-03 |
| Stage1-vs-Stage4 |
1.839030E-03 |
| Stage2-vs-Stage3 |
8.200000E-03 |
| Stage2-vs-Stage4 |
4.159500E-03 |
| Stage3-vs-Stage4 |
3.727200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.55351295663786E-15 |
| Normal-vs-AfricanAmerican |
1.49840000407409E-08 |
| Normal-vs-Asian |
8.88178419700125E-15 |
| Caucasian-vs-AfricanAmerican |
6.806600E-01 |
| Caucasian-vs-Asian |
6.575900E-02 |
| AfricanAmerican-vs-Asian |
4.700800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.70100000038443E-08 |
| Normal-vs-Female |
4.03719946362457E-10 |
| Male-vs-Female |
5.925600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1434999997183E-08 |
| Normal-vs-Age(41-60Yrs) |
1.23129995088789E-09 |
| Normal-vs-Age(61-80Yrs) |
2.54349874495574E-11 |
| Normal-vs-Age(81-100Yrs) |
1.793660E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.812200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.144600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.037400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.499200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.494400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.148800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.55020021661312E-10 |
| Classical-VS-Follicular |
2.06289999999942E-05 |
| Classical-VS-Other |
5.852000E-01 |
| Classical-VS-Normal |
1.62647673107585E-12 |
| Tall-VS-Follicular |
5.95560000204998E-08 |
| Tall-VS-Other |
1.678360E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.537600E-02 |
| Follicular-VS-Normal |
5.914400E-01 |
| Other-VS-Normal |
4.597300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.1792000000005E-05 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.97950000005542E-07 |
|
|
